Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making?
作者: Carlos Castañeda-OrjuelaMario García-MolinaFernando De la Hoz-Restrepo
作者单位: 1Epidemiology and Public Health Evaluation Group, Public Health Department, Universidad Nacional de Colombia, Bogotá, Colombia
2Colombian National Health Observatory, Instituto Nacional de Salud, Bogotá, Colombia
3School of Economics, Universidad Nacional de Colombia, Bogotá, Colombia
刊名: Value in Health Regional Issues, 2020, Vol.23 , pp.1-5
来源数据库: Elsevier Journal
DOI: 10.1016/j.vhri.2019.09.009
关键词: BiomedicalCost-benefit analysisDecision makingPublic healthTechnology assessment
英文摘要: Abstract(#br)Healthcare costs are a concern for the sustainability of health systems in both rich and poor countries. Achieving a balance between the aspirations of payers and the manufacturers of new technologies is a challenge for democratic societies. Evidence about the efficacy and effectiveness of a new intervention is a fundamental aspect for its inclusion, but additional information about organization, implementation, and feasibility is required. Economic evaluations, especially cost-effectiveness analyses (CEA), help inform the choice of a particular health intervention, but they are not the only input for decision making (DM). Use of CEA is relatively recent but has quickly become widespread. CEA techniques have evolved into increasingly complex and sophisticated methods intended...
全文获取路径: Elsevier  (合作)

  • Analysis 分析